Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nkx2-2
|
ENSMUSG00000027434.10 | NK2 homeobox 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_147235847_147236238 | Nkx2-2 | 41799 | 0.102696 | -0.60 | 3.4e-07 | Click! |
chr2_147193017_147193476 | Nkx2-2 | 996 | 0.476956 | -0.43 | 5.8e-04 | Click! |
chr2_147191734_147192152 | Nkx2-2 | 2299 | 0.233005 | -0.43 | 6.0e-04 | Click! |
chr2_147191459_147191628 | Nkx2-2 | 2699 | 0.208271 | -0.41 | 1.1e-03 | Click! |
chr2_147192844_147192995 | Nkx2-2 | 1323 | 0.371584 | -0.28 | 3.2e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_71019478_71020561 | 5.86 |
Myom1 |
myomesin 1 |
428 |
0.76 |
chr1_58970537_58971332 | 4.97 |
Trak2 |
trafficking protein, kinesin binding 2 |
2495 |
0.2 |
chr1_51288641_51290950 | 4.21 |
Cavin2 |
caveolae associated 2 |
669 |
0.72 |
chr14_32167841_32168504 | 4.10 |
Ncoa4 |
nuclear receptor coactivator 4 |
2051 |
0.19 |
chr11_72409874_72410296 | 3.65 |
Smtnl2 |
smoothelin-like 2 |
1626 |
0.27 |
chr3_100485235_100486511 | 3.57 |
Tent5c |
terminal nucleotidyltransferase 5C |
3321 |
0.18 |
chr18_60500309_60500522 | 3.53 |
Smim3 |
small integral membrane protein 3 |
1161 |
0.44 |
chr13_45906480_45907006 | 3.47 |
4930453C13Rik |
RIKEN cDNA 4930453C13 gene |
29297 |
0.18 |
chr8_35377821_35378531 | 3.46 |
Ppp1r3b |
protein phosphatase 1, regulatory subunit 3B |
1516 |
0.31 |
chr11_22170035_22170326 | 3.45 |
Ehbp1 |
EH domain binding protein 1 |
1230 |
0.61 |
chr3_116563017_116563467 | 3.45 |
Lrrc39 |
leucine rich repeat containing 39 |
264 |
0.81 |
chr8_57319308_57320679 | 3.34 |
Hand2os1 |
Hand2, opposite strand 1 |
63 |
0.94 |
chr15_25941347_25942080 | 3.30 |
Retreg1 |
reticulophagy regulator 1 |
826 |
0.63 |
chr4_87804582_87805116 | 3.25 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
1445 |
0.57 |
chr19_45446379_45446948 | 3.22 |
Btrc |
beta-transducin repeat containing protein |
1155 |
0.47 |
chr16_32610201_32610589 | 3.15 |
Tfrc |
transferrin receptor |
1145 |
0.41 |
chr1_131638462_131638811 | 3.15 |
Ctse |
cathepsin E |
142 |
0.95 |
chr6_48707462_48707684 | 3.13 |
Gimap6 |
GTPase, IMAP family member 6 |
623 |
0.46 |
chr6_142700636_142701025 | 3.10 |
Abcc9 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
1388 |
0.47 |
chr10_40140777_40141166 | 3.09 |
Slc16a10 |
solute carrier family 16 (monocarboxylic acid transporters), member 10 |
1283 |
0.36 |
chr1_165462988_165463362 | 3.05 |
Mpc2 |
mitochondrial pyruvate carrier 2 |
1810 |
0.18 |
chr2_119619277_119620230 | 3.03 |
Nusap1 |
nucleolar and spindle associated protein 1 |
1024 |
0.3 |
chr2_84475523_84476677 | 3.03 |
Tfpi |
tissue factor pathway inhibitor |
648 |
0.7 |
chr15_55904618_55905390 | 2.98 |
Sntb1 |
syntrophin, basic 1 |
1306 |
0.42 |
chr9_90269705_90269965 | 2.95 |
Tbc1d2b |
TBC1 domain family, member 2B |
934 |
0.55 |
chr9_70680771_70681491 | 2.94 |
Adam10 |
a disintegrin and metallopeptidase domain 10 |
2115 |
0.3 |
chr15_41751298_41752572 | 2.93 |
Oxr1 |
oxidation resistance 1 |
234 |
0.95 |
chr6_112459682_112460792 | 2.93 |
Cav3 |
caveolin 3 |
732 |
0.65 |
chr15_25942218_25942426 | 2.91 |
Retreg1 |
reticulophagy regulator 1 |
357 |
0.88 |
chr16_16526595_16527684 | 2.90 |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
272 |
0.92 |
chr9_101196762_101197254 | 2.89 |
Ppp2r3a |
protein phosphatase 2, regulatory subunit B'', alpha |
1843 |
0.24 |
chr12_91745342_91746056 | 2.89 |
Ston2 |
stonin 2 |
385 |
0.85 |
chr13_51646613_51647088 | 2.89 |
Gm22806 |
predicted gene, 22806 |
1349 |
0.33 |
chr5_32137287_32137577 | 2.80 |
Fosl2 |
fos-like antigen 2 |
1259 |
0.39 |
chr16_38364563_38365451 | 2.80 |
Popdc2 |
popeye domain containing 2 |
2762 |
0.17 |
chr19_53680794_53681963 | 2.79 |
Rbm20 |
RNA binding motif protein 20 |
4072 |
0.23 |
chr6_55336550_55338274 | 2.79 |
Aqp1 |
aquaporin 1 |
980 |
0.5 |
chr2_91120400_91120551 | 2.73 |
Mybpc3 |
myosin binding protein C, cardiac |
2331 |
0.18 |
chr4_87805839_87806716 | 2.71 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
17 |
0.99 |
chr2_158145151_158146425 | 2.66 |
Tgm2 |
transglutaminase 2, C polypeptide |
578 |
0.71 |
chr7_45523041_45524800 | 2.66 |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
151 |
0.85 |
chr3_65954778_65955426 | 2.64 |
Ccnl1 |
cyclin L1 |
1754 |
0.22 |
chr18_32557788_32558922 | 2.60 |
Gypc |
glycophorin C |
1625 |
0.41 |
chr3_68056879_68057194 | 2.56 |
Schip1 |
schwannomin interacting protein 1 |
7766 |
0.3 |
chr3_97033266_97033458 | 2.55 |
Gja5 |
gap junction protein, alpha 5 |
946 |
0.54 |
chr2_19660039_19660459 | 2.54 |
Otud1 |
OTU domain containing 1 |
2497 |
0.19 |
chr9_75775275_75776608 | 2.53 |
Bmp5 |
bone morphogenetic protein 5 |
577 |
0.78 |
chrY_4319249_4319558 | 2.52 |
Gm28186 |
predicted gene 28186 |
6821 |
0.23 |
chr7_75612178_75613652 | 2.50 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
631 |
0.75 |
chr18_62178475_62179981 | 2.50 |
Adrb2 |
adrenergic receptor, beta 2 |
731 |
0.49 |
chr3_152191751_152192635 | 2.49 |
Dnajb4 |
DnaJ heat shock protein family (Hsp40) member B4 |
1652 |
0.26 |
chr10_115817324_115818606 | 2.49 |
Tspan8 |
tetraspanin 8 |
681 |
0.78 |
chr15_40673370_40673521 | 2.46 |
Zfpm2 |
zinc finger protein, multitype 2 |
8455 |
0.3 |
chr1_165114989_165115491 | 2.44 |
4930568G15Rik |
RIKEN cDNA 4930568G15 gene |
23312 |
0.14 |
chr4_119110568_119111095 | 2.44 |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
1917 |
0.2 |
chr1_191394109_191394706 | 2.42 |
Ppp2r5a |
protein phosphatase 2, regulatory subunit B', alpha |
1912 |
0.28 |
chr6_120035887_120036069 | 2.40 |
Mir706 |
microRNA 706 |
1667 |
0.28 |
chr6_136855871_136856717 | 2.40 |
Art4 |
ADP-ribosyltransferase 4 |
1439 |
0.23 |
chr7_3292731_3293965 | 2.39 |
Myadm |
myeloid-associated differentiation marker |
254 |
0.81 |
chr17_81733494_81733965 | 2.37 |
Slc8a1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
4648 |
0.31 |
chr9_77637137_77637792 | 2.37 |
Klhl31 |
kelch-like 31 |
964 |
0.54 |
chr1_52008591_52009314 | 2.36 |
Stat4 |
signal transducer and activator of transcription 4 |
326 |
0.88 |
chr3_148922933_148923187 | 2.34 |
Adgrl2 |
adhesion G protein-coupled receptor L2 |
31575 |
0.19 |
chr4_40851422_40852119 | 2.32 |
Gm25931 |
predicted gene, 25931 |
1368 |
0.21 |
chr6_134780949_134781457 | 2.32 |
Dusp16 |
dual specificity phosphatase 16 |
10131 |
0.15 |
chr3_14890853_14891237 | 2.30 |
Car2 |
carbonic anhydrase 2 |
4406 |
0.22 |
chr10_58396489_58397099 | 2.30 |
Lims1 |
LIM and senescent cell antigen-like domains 1 |
2406 |
0.3 |
chr16_58671576_58671902 | 2.28 |
Cpox |
coproporphyrinogen oxidase |
1411 |
0.31 |
chr17_69395929_69396464 | 2.26 |
Gm49894 |
predicted gene, 49894 |
11988 |
0.14 |
chr1_64734585_64735561 | 2.24 |
Gm38058 |
predicted gene, 38058 |
1167 |
0.41 |
chr6_41702817_41703169 | 2.24 |
Kel |
Kell blood group |
1346 |
0.32 |
chr14_70706940_70707491 | 2.23 |
Xpo7 |
exportin 7 |
820 |
0.57 |
chr9_24771894_24772338 | 2.23 |
Tbx20 |
T-box 20 |
2168 |
0.29 |
chr10_5802794_5803189 | 2.22 |
Fbxo5 |
F-box protein 5 |
1609 |
0.42 |
chr2_114048099_114048464 | 2.21 |
Actc1 |
actin, alpha, cardiac muscle 1 |
4606 |
0.18 |
chrY_1041845_1042254 | 2.21 |
Gm29650 |
predicted gene 29650 |
6344 |
0.16 |
chr14_101888494_101888858 | 2.20 |
Lmo7 |
LIM domain only 7 |
4557 |
0.31 |
chr12_35533032_35533561 | 2.19 |
Gm48236 |
predicted gene, 48236 |
1125 |
0.37 |
chr13_22021296_22022115 | 2.18 |
Gm11290 |
predicted gene 11290 |
4199 |
0.06 |
chr10_40164584_40165218 | 2.16 |
Gm31992 |
predicted gene, 31992 |
791 |
0.53 |
chr11_51620666_51620847 | 2.16 |
Nhp2 |
NHP2 ribonucleoprotein |
985 |
0.4 |
chr10_3368375_3368998 | 2.15 |
Ppp1r14c |
protein phosphatase 1, regulatory inhibitor subunit 14C |
2142 |
0.36 |
chrX_42152430_42152678 | 2.13 |
Stag2 |
stromal antigen 2 |
374 |
0.84 |
chr3_116125884_116126431 | 2.13 |
Gm43109 |
predicted gene 43109 |
2294 |
0.2 |
chr19_36734732_36735279 | 2.12 |
Ppp1r3c |
protein phosphatase 1, regulatory subunit 3C |
1648 |
0.41 |
chr5_116421567_116422547 | 2.12 |
Hspb8 |
heat shock protein 8 |
807 |
0.51 |
chr7_133700764_133701966 | 2.10 |
Uros |
uroporphyrinogen III synthase |
1173 |
0.35 |
chr12_105034229_105034527 | 2.10 |
Glrx5 |
glutaredoxin 5 |
838 |
0.39 |
chr10_93142710_93143193 | 2.10 |
Cdk17 |
cyclin-dependent kinase 17 |
17924 |
0.17 |
chr6_136856791_136856995 | 2.10 |
Art4 |
ADP-ribosyltransferase 4 |
840 |
0.41 |
chr8_68119212_68120289 | 2.09 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
1563 |
0.51 |
chr14_57034631_57034809 | 2.08 |
B020004C17Rik |
RIKEN cDNA B020004C17 gene |
19586 |
0.15 |
chr16_87611121_87611369 | 2.08 |
Gm22808 |
predicted gene, 22808 |
9875 |
0.19 |
chr2_79256898_79257323 | 2.08 |
Itga4 |
integrin alpha 4 |
1163 |
0.57 |
chr10_39613682_39614138 | 2.08 |
Gm16364 |
predicted gene 16364 |
228 |
0.85 |
chr19_6384347_6385874 | 2.07 |
Pygm |
muscle glycogen phosphorylase |
695 |
0.45 |
chr16_57551520_57552150 | 2.06 |
Filip1l |
filamin A interacting protein 1-like |
2593 |
0.35 |
chr9_79976568_79977294 | 2.06 |
Filip1 |
filamin A interacting protein 1 |
728 |
0.66 |
chr9_43101838_43102807 | 2.06 |
Arhgef12 |
Rho guanine nucleotide exchange factor (GEF) 12 |
3164 |
0.24 |
chr2_17459795_17460084 | 2.05 |
Nebl |
nebulette |
682 |
0.8 |
chr13_52584896_52585203 | 2.04 |
Syk |
spleen tyrosine kinase |
1546 |
0.51 |
chr2_19661271_19661512 | 2.04 |
Otud1 |
OTU domain containing 1 |
3639 |
0.16 |
chr14_21659365_21659766 | 2.04 |
Kat6b |
K(lysine) acetyltransferase 6B |
33813 |
0.15 |
chr3_60531956_60532107 | 2.04 |
Mbnl1 |
muscleblind like splicing factor 1 |
2400 |
0.3 |
chr7_98084990_98085141 | 2.04 |
Myo7a |
myosin VIIA |
346 |
0.89 |
chr7_100492685_100494805 | 2.03 |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
50 |
0.95 |
chr3_27983796_27984084 | 2.03 |
Pld1 |
phospholipase D1 |
231 |
0.96 |
chr17_79353619_79354242 | 2.03 |
CT030740.1 |
novel transcript, antisense to Cdc42ep3 |
769 |
0.49 |
chr7_112228733_112229227 | 2.03 |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
3090 |
0.35 |
chrX_53053916_53055220 | 2.02 |
Mir322 |
microRNA 322 |
219 |
0.66 |
chr4_156254311_156255909 | 2.01 |
Samd11 |
sterile alpha motif domain containing 11 |
106 |
0.87 |
chr19_24553917_24554867 | 2.01 |
Pip5k1b |
phosphatidylinositol-4-phosphate 5-kinase, type 1 beta |
1397 |
0.38 |
chr11_40754069_40754308 | 2.00 |
Ccng1 |
cyclin G1 |
250 |
0.92 |
chr10_111167681_111168396 | 2.00 |
Osbpl8 |
oxysterol binding protein-like 8 |
3236 |
0.18 |
chr6_119194389_119194967 | 2.00 |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
1553 |
0.37 |
chr10_33255178_33255436 | 1.99 |
D830005E20Rik |
RIKEN cDNA D830005E20 gene |
1050 |
0.52 |
chr1_85736164_85736622 | 1.99 |
A630001G21Rik |
RIKEN cDNA A630001G21 gene |
161 |
0.92 |
chr17_86536044_86537023 | 1.99 |
Gm10309 |
predicted gene 10309 |
31301 |
0.19 |
chr14_8171936_8172094 | 1.98 |
Pdhb |
pyruvate dehydrogenase (lipoamide) beta |
274 |
0.91 |
chr4_19707962_19708199 | 1.97 |
Wwp1 |
WW domain containing E3 ubiquitin protein ligase 1 |
913 |
0.62 |
chr11_85843375_85844753 | 1.96 |
Gm11444 |
predicted gene 11444 |
6269 |
0.14 |
chr5_75975825_75977229 | 1.96 |
Kdr |
kinase insert domain protein receptor |
1931 |
0.31 |
chr17_71204583_71205351 | 1.96 |
Lpin2 |
lipin 2 |
291 |
0.89 |
chr1_161071918_161072475 | 1.95 |
Cenpl |
centromere protein L |
209 |
0.8 |
chr10_69786998_69788126 | 1.94 |
Ank3 |
ankyrin 3, epithelial |
106 |
0.98 |
chr14_66999128_66999279 | 1.94 |
Bnip3l |
BCL2/adenovirus E1B interacting protein 3-like |
454 |
0.77 |
chr19_5724785_5726881 | 1.94 |
Ehbp1l1 |
EH domain binding protein 1-like 1 |
437 |
0.54 |
chr4_132397142_132397510 | 1.93 |
Phactr4 |
phosphatase and actin regulator 4 |
873 |
0.38 |
chr2_163395028_163395405 | 1.92 |
Jph2 |
junctophilin 2 |
2733 |
0.2 |
chr1_97761021_97761213 | 1.92 |
Ppip5k2 |
diphosphoinositol pentakisphosphate kinase 2 |
421 |
0.85 |
chrX_53267645_53268215 | 1.92 |
Fam122b |
family with sequence similarity 122, member B |
1090 |
0.45 |
chr7_17059938_17060640 | 1.91 |
4833404L02Rik |
RIKEN cDNA 4833404L02 gene |
1755 |
0.2 |
chr4_62517192_62517621 | 1.90 |
Alad |
aminolevulinate, delta-, dehydratase |
2475 |
0.17 |
chr10_53337944_53338408 | 1.90 |
Pln |
phospholamban |
471 |
0.73 |
chr10_19593516_19594017 | 1.90 |
Ifngr1 |
interferon gamma receptor 1 |
1693 |
0.36 |
chr10_123195629_123195947 | 1.89 |
Gm4129 |
predicted gene 4129 |
907 |
0.34 |
chr6_38351696_38352191 | 1.89 |
Zc3hav1 |
zinc finger CCCH type, antiviral 1 |
2330 |
0.21 |
chr8_60973849_60974245 | 1.88 |
Clcn3 |
chloride channel, voltage-sensitive 3 |
9192 |
0.15 |
chr16_16215496_16216272 | 1.87 |
Pkp2 |
plakophilin 2 |
2566 |
0.29 |
chr10_127748215_127748437 | 1.87 |
Gpr182 |
G protein-coupled receptor 182 |
3406 |
0.1 |
chr16_75908561_75908874 | 1.86 |
Samsn1 |
SAM domain, SH3 domain and nuclear localization signals, 1 |
562 |
0.83 |
chr5_76859510_76859661 | 1.86 |
C530008M17Rik |
RIKEN cDNA C530008M17 gene |
743 |
0.64 |
chr14_79515651_79516545 | 1.86 |
Elf1 |
E74-like factor 1 |
400 |
0.83 |
chr7_110124152_110124626 | 1.86 |
Wee1 |
WEE 1 homolog 1 (S. pombe) |
2343 |
0.2 |
chr7_103814530_103814805 | 1.86 |
Hbb-bt |
hemoglobin, beta adult t chain |
671 |
0.4 |
chr18_4993802_4994475 | 1.85 |
Svil |
supervillin |
325 |
0.94 |
chrX_106839224_106840351 | 1.84 |
Rtl3 |
retrotransposon Gag like 3 |
857 |
0.6 |
chr8_22506948_22507557 | 1.84 |
Slc20a2 |
solute carrier family 20, member 2 |
1026 |
0.46 |
chr7_48847211_48847926 | 1.84 |
Csrp3 |
cysteine and glycine-rich protein 3 |
465 |
0.76 |
chr8_67950091_67950348 | 1.84 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
1660 |
0.41 |
chr1_135132701_135133163 | 1.84 |
Ptpn7 |
protein tyrosine phosphatase, non-receptor type 7 |
207 |
0.62 |
chr6_48739497_48740057 | 1.84 |
Gimap1 |
GTPase, IMAP family member 1 |
670 |
0.27 |
chr13_45681272_45681423 | 1.84 |
Gm47460 |
predicted gene, 47460 |
68225 |
0.12 |
chr5_96911434_96911981 | 1.82 |
Gm43147 |
predicted gene 43147 |
1534 |
0.22 |
chr1_91055638_91056072 | 1.82 |
Lrrfip1 |
leucine rich repeat (in FLII) interacting protein 1 |
2269 |
0.31 |
chr5_129005766_129006301 | 1.81 |
Stx2 |
syntaxin 2 |
2390 |
0.3 |
chr3_97076352_97076977 | 1.81 |
4930573H18Rik |
RIKEN cDNA 4930573H18 gene |
16121 |
0.15 |
chr7_132775313_132775854 | 1.80 |
Fam53b |
family with sequence similarity 53, member B |
1333 |
0.46 |
chr15_78899791_78900874 | 1.80 |
Sh3bp1 |
SH3-domain binding protein 1 |
96 |
0.86 |
chr4_13832780_13832954 | 1.80 |
Runx1t1 |
RUNX1 translocation partner 1 |
48085 |
0.18 |
chr2_167698185_167698366 | 1.80 |
A530013C23Rik |
RIKEN cDNA A530013C23 gene |
7094 |
0.12 |
chr10_5287995_5289689 | 1.80 |
Gm23573 |
predicted gene, 23573 |
68331 |
0.12 |
chr11_95344184_95344738 | 1.80 |
Fam117a |
family with sequence similarity 117, member A |
4499 |
0.14 |
chr6_3398628_3399056 | 1.80 |
Samd9l |
sterile alpha motif domain containing 9-like |
730 |
0.64 |
chr6_94183402_94184029 | 1.80 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
99310 |
0.08 |
chr6_98105417_98106059 | 1.80 |
Gm32592 |
predicted gene, 32592 |
16058 |
0.28 |
chr8_82401863_82403222 | 1.80 |
Il15 |
interleukin 15 |
28 |
0.98 |
chr2_26013333_26013580 | 1.80 |
Ubac1 |
ubiquitin associated domain containing 1 |
2503 |
0.2 |
chr18_10785293_10785854 | 1.78 |
Mir1a-2 |
microRNA 1a-2 |
21 |
0.55 |
chr10_18845717_18847414 | 1.78 |
Perp |
PERP, TP53 apoptosis effector |
1545 |
0.37 |
chr6_149311044_149311225 | 1.78 |
Resf1 |
retroelement silencing factor 1 |
282 |
0.89 |
chr5_139390751_139391547 | 1.78 |
Gpr146 |
G protein-coupled receptor 146 |
1364 |
0.29 |
chr15_53310669_53311940 | 1.78 |
Ext1 |
exostosin glycosyltransferase 1 |
34355 |
0.22 |
chr14_61683887_61685176 | 1.78 |
Gm37820 |
predicted gene, 37820 |
1021 |
0.34 |
chr5_151418570_151418800 | 1.78 |
Gm42906 |
predicted gene 42906 |
9478 |
0.16 |
chr3_145989563_145989714 | 1.77 |
Syde2 |
synapse defective 1, Rho GTPase, homolog 2 (C. elegans) |
985 |
0.54 |
chr19_7558753_7558904 | 1.77 |
Plaat3 |
phospholipase A and acyltransferase 3 |
1343 |
0.39 |
chr12_117657998_117660727 | 1.77 |
Rapgef5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
1328 |
0.51 |
chr6_41700699_41701150 | 1.76 |
Kel |
Kell blood group |
1756 |
0.24 |
chr4_46040988_46042013 | 1.76 |
Tmod1 |
tropomodulin 1 |
2291 |
0.3 |
chr10_127311837_127312214 | 1.76 |
Mars1 |
methionine-tRNA synthetase 1 |
239 |
0.76 |
chr18_61785451_61786937 | 1.76 |
Afap1l1 |
actin filament associated protein 1-like 1 |
417 |
0.83 |
chr3_41522196_41522994 | 1.76 |
2400006E01Rik |
RIKEN cDNA 2400006E01 gene |
622 |
0.65 |
chr11_5802324_5803834 | 1.76 |
Pgam2 |
phosphoglycerate mutase 2 |
654 |
0.56 |
chr5_105523041_105523801 | 1.75 |
Lrrc8c |
leucine rich repeat containing 8 family, member C |
3948 |
0.23 |
chr1_34120973_34122005 | 1.75 |
Dst |
dystonin |
239 |
0.92 |
chr10_108434849_108435510 | 1.75 |
Gm36283 |
predicted gene, 36283 |
1486 |
0.41 |
chr15_83169748_83171160 | 1.74 |
Cyb5r3 |
cytochrome b5 reductase 3 |
52 |
0.95 |
chr4_102568544_102569595 | 1.74 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
1026 |
0.69 |
chr11_4576729_4576918 | 1.74 |
Gm11960 |
predicted gene 11960 |
13191 |
0.15 |
chr14_55604116_55604924 | 1.74 |
Irf9 |
interferon regulatory factor 9 |
57 |
0.9 |
chr5_119449138_119449362 | 1.74 |
Gm31314 |
predicted gene, 31314 |
78704 |
0.09 |
chr7_31040855_31042728 | 1.73 |
Fxyd5 |
FXYD domain-containing ion transport regulator 5 |
48 |
0.93 |
chr11_95840624_95841423 | 1.73 |
Abi3 |
ABI gene family, member 3 |
1075 |
0.28 |
chr3_60409216_60409437 | 1.73 |
Mbnl1 |
muscleblind like splicing factor 1 |
63504 |
0.12 |
chr18_38917847_38919046 | 1.73 |
Fgf1 |
fibroblast growth factor 1 |
325 |
0.9 |
chr5_143625482_143626083 | 1.73 |
Cyth3 |
cytohesin 3 |
3248 |
0.24 |
chr6_125349409_125350825 | 1.72 |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
394 |
0.77 |
chr1_147556449_147556600 | 1.72 |
Gm38284 |
predicted gene, 38284 |
40798 |
0.19 |
chr16_36934847_36935880 | 1.72 |
Hcls1 |
hematopoietic cell specific Lyn substrate 1 |
380 |
0.77 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 2.6 | GO:0048769 | sarcomerogenesis(GO:0048769) |
1.6 | 6.6 | GO:0035995 | detection of muscle stretch(GO:0035995) |
1.6 | 8.0 | GO:0003175 | tricuspid valve development(GO:0003175) |
1.4 | 7.0 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
1.4 | 2.7 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.3 | 4.0 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
1.3 | 3.8 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
1.2 | 4.8 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
1.1 | 3.4 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
1.1 | 3.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.0 | 2.0 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
1.0 | 2.9 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.0 | 2.9 | GO:0002086 | diaphragm contraction(GO:0002086) |
1.0 | 2.9 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.9 | 2.8 | GO:0046077 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.9 | 2.8 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.9 | 3.6 | GO:2000065 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.9 | 4.4 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.9 | 2.6 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.8 | 2.5 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.8 | 2.5 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.8 | 0.8 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.8 | 2.4 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.8 | 2.4 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.8 | 2.4 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.8 | 1.6 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.8 | 3.1 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.7 | 2.2 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.7 | 2.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.7 | 5.2 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.7 | 2.9 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.7 | 1.4 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.7 | 1.4 | GO:0008228 | opsonization(GO:0008228) |
0.7 | 3.5 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.7 | 3.5 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.7 | 1.4 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.7 | 2.0 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
0.7 | 3.4 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.7 | 2.0 | GO:0070836 | caveola assembly(GO:0070836) |
0.7 | 2.0 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.7 | 3.3 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.6 | 2.6 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.6 | 0.6 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.6 | 1.9 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.6 | 1.9 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.6 | 4.9 | GO:0033572 | transferrin transport(GO:0033572) |
0.6 | 1.8 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.6 | 3.0 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.6 | 1.8 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.6 | 1.8 | GO:0050904 | diapedesis(GO:0050904) |
0.6 | 2.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.6 | 0.6 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.6 | 1.7 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.6 | 2.3 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
0.6 | 2.8 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
0.6 | 2.3 | GO:0046618 | drug export(GO:0046618) |
0.6 | 0.6 | GO:0072567 | chemokine (C-X-C motif) ligand 2 production(GO:0072567) |
0.5 | 2.2 | GO:0006848 | pyruvate transport(GO:0006848) |
0.5 | 0.5 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.5 | 2.1 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.5 | 2.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.5 | 1.5 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.5 | 0.5 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.5 | 0.5 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.5 | 3.9 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.5 | 1.0 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.5 | 1.4 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.5 | 2.4 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.5 | 1.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.5 | 1.9 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.5 | 0.5 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.5 | 0.5 | GO:0019660 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.5 | 3.7 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.5 | 1.4 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.5 | 1.8 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.5 | 1.4 | GO:0032439 | endosome localization(GO:0032439) |
0.5 | 0.5 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.4 | 1.8 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.4 | 2.2 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.4 | 0.4 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
0.4 | 0.4 | GO:0003163 | sinoatrial node development(GO:0003163) |
0.4 | 3.5 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.4 | 0.9 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.4 | 1.7 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.4 | 1.7 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.4 | 3.9 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.4 | 1.3 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.4 | 1.3 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.4 | 1.3 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.4 | 2.5 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.4 | 3.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.4 | 0.4 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.4 | 1.2 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.4 | 1.2 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.4 | 1.6 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.4 | 1.6 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.4 | 0.8 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) |
0.4 | 1.2 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.4 | 1.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.4 | 1.2 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.4 | 3.6 | GO:0009301 | snRNA transcription(GO:0009301) |
0.4 | 1.2 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.4 | 1.6 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.4 | 1.6 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.4 | 1.5 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.4 | 1.5 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.4 | 1.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.4 | 1.9 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.4 | 0.4 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.4 | 1.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.4 | 1.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.4 | 1.5 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.4 | 0.8 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.4 | 2.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.4 | 1.1 | GO:0046084 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.4 | 0.7 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.4 | 3.7 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.4 | 1.1 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.4 | 1.5 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.4 | 1.1 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.4 | 1.1 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.4 | 0.7 | GO:1902488 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.4 | 3.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.4 | 1.8 | GO:0030578 | PML body organization(GO:0030578) |
0.4 | 0.4 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.4 | 1.5 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.4 | 1.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.4 | 0.7 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.4 | 1.8 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.4 | 0.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.4 | 5.3 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.4 | 0.7 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.4 | 1.1 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.4 | 1.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.4 | 0.4 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.4 | 5.3 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.3 | 0.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.3 | 4.9 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.3 | 0.7 | GO:0072125 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
0.3 | 1.7 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.3 | 1.7 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.3 | 0.3 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.3 | 0.7 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.3 | 1.0 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.3 | 1.4 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.3 | 1.4 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.3 | 1.0 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.3 | 1.0 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.3 | 1.3 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.3 | 1.3 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.3 | 2.0 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.3 | 1.3 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.3 | 1.3 | GO:0009115 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.3 | 2.7 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.3 | 1.0 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.3 | 1.7 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.3 | 1.3 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.3 | 1.3 | GO:0018214 | protein carboxylation(GO:0018214) |
0.3 | 1.0 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.3 | 1.0 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.3 | 1.3 | GO:1903278 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.3 | 1.0 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.3 | 1.0 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.3 | 1.3 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
0.3 | 1.0 | GO:0006971 | hypotonic response(GO:0006971) |
0.3 | 0.3 | GO:0061439 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) |
0.3 | 1.0 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.3 | 0.3 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.3 | 0.3 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.3 | 0.9 | GO:0072276 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.3 | 0.6 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.3 | 0.9 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.3 | 0.9 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.3 | 1.3 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.3 | 1.6 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.3 | 0.6 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.3 | 0.9 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.3 | 0.6 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.3 | 3.4 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.3 | 0.9 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.3 | 0.9 | GO:0021564 | vagus nerve development(GO:0021564) |
0.3 | 0.3 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.3 | 1.2 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.3 | 1.2 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.3 | 0.3 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.3 | 1.5 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.3 | 2.7 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.3 | 0.6 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.3 | 2.1 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.3 | 0.3 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.3 | 0.3 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.3 | 1.8 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.3 | 0.6 | GO:0071971 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
0.3 | 0.6 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.3 | 0.9 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.3 | 1.8 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 0.6 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.3 | 0.9 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.3 | 2.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.3 | 2.0 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.3 | 0.6 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.3 | 0.9 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.3 | 0.9 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.3 | 1.4 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.3 | 1.2 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.3 | 0.6 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.3 | 2.9 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.3 | 0.6 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
0.3 | 0.3 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.3 | 0.9 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.3 | 0.3 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.3 | 0.6 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.3 | 0.6 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.3 | 2.0 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.3 | 1.1 | GO:0001802 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.3 | 2.8 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.3 | 1.4 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.3 | 1.4 | GO:0097531 | mast cell migration(GO:0097531) |
0.3 | 0.6 | GO:0009158 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.3 | 0.6 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.3 | 2.2 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.3 | 1.1 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.3 | 1.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.3 | 0.8 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.3 | 3.3 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 1.4 | GO:0072711 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.3 | 1.7 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.3 | 0.6 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.3 | 1.1 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.3 | 0.6 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.3 | 0.3 | GO:2000553 | regulation of T-helper 2 cell cytokine production(GO:2000551) positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.3 | 1.9 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.3 | 0.3 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.3 | 0.3 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.3 | 1.6 | GO:0031274 | regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.3 | 1.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.3 | 2.2 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.3 | 0.5 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.3 | 1.4 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.3 | 1.1 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.3 | 0.5 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.3 | 1.3 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.3 | 0.8 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.3 | 1.9 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.3 | 2.9 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.3 | 1.1 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
0.3 | 1.1 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.3 | 1.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.3 | 0.8 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.3 | 1.6 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.3 | 0.3 | GO:0045472 | response to ether(GO:0045472) |
0.3 | 1.8 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 1.3 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.3 | 2.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.3 | 1.8 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.3 | 5.2 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.3 | 0.8 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.3 | 0.8 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.3 | 1.0 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.3 | 1.3 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.3 | 0.5 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.3 | 1.0 | GO:0086013 | membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
0.3 | 1.5 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.3 | 1.0 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.3 | 1.8 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.3 | 0.3 | GO:0071451 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.3 | 0.3 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.3 | 0.8 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.2 | 1.7 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 0.7 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.2 | 0.5 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.2 | 1.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 1.2 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.2 | 0.7 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.2 | 0.2 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.2 | 1.5 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.2 | 0.7 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.2 | 0.2 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.2 | 0.5 | GO:0031033 | myosin filament organization(GO:0031033) |
0.2 | 0.5 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.2 | 0.7 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 0.2 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.2 | 1.7 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.2 | 0.2 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.2 | 0.7 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.2 | 1.0 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.2 | 0.5 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.2 | 0.7 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.2 | 1.0 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 1.9 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 1.0 | GO:0035482 | gastric motility(GO:0035482) |
0.2 | 0.2 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.2 | 1.0 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.2 | 0.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.2 | 1.2 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 0.7 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.2 | 0.7 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.2 | 0.9 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.2 | 0.9 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.2 | 0.5 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.2 | 1.4 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 0.7 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.2 | 0.7 | GO:0044838 | cell quiescence(GO:0044838) |
0.2 | 1.8 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.2 | 0.5 | GO:0042023 | DNA endoreduplication(GO:0042023) |
0.2 | 0.7 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.2 | 0.7 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.2 | 1.3 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.2 | 0.2 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.2 | 0.7 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 0.7 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.2 | 1.1 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.2 | 0.9 | GO:0002934 | desmosome organization(GO:0002934) |
0.2 | 1.8 | GO:0001553 | luteinization(GO:0001553) |
0.2 | 0.9 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.2 | 0.7 | GO:0015819 | lysine transport(GO:0015819) |
0.2 | 0.2 | GO:0071285 | response to lithium ion(GO:0010226) cellular response to lithium ion(GO:0071285) |
0.2 | 6.6 | GO:0030239 | myofibril assembly(GO:0030239) |
0.2 | 2.6 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.2 | 0.7 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.2 | 0.7 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 0.4 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.2 | 0.7 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
0.2 | 0.2 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.2 | 0.9 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 0.6 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.2 | 0.2 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.2 | 1.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.2 | 0.9 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.2 | 0.2 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.2 | 0.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.2 | 1.9 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.2 | 0.4 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 0.4 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.2 | 0.6 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.2 | 0.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.2 | 3.6 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 1.1 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.2 | 0.2 | GO:0036394 | amylase secretion(GO:0036394) |
0.2 | 0.2 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.2 | 0.4 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.2 | 0.6 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.2 | 0.2 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.2 | 0.6 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 1.6 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 0.6 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 1.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.2 | 0.2 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.2 | 2.0 | GO:0051383 | kinetochore organization(GO:0051383) |
0.2 | 0.6 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 0.6 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.2 | 0.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.2 | 0.4 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
0.2 | 0.8 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.2 | 0.4 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.2 | 0.4 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.2 | 0.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.2 | 0.2 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.2 | 0.8 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.2 | 0.4 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.2 | 1.2 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.2 | 0.2 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.2 | 0.2 | GO:0035733 | hepatic stellate cell activation(GO:0035733) |
0.2 | 0.4 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.2 | 0.6 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.2 | 1.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 1.2 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.2 | 1.9 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.6 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 0.4 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.2 | 0.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 0.8 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.2 | 0.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.2 | 0.2 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.2 | 0.4 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.2 | 0.6 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.2 | 0.4 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.2 | 0.2 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.2 | 4.9 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.2 | 1.1 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.2 | 0.2 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.2 | 0.4 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.2 | 0.2 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.2 | 0.6 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.2 | 2.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.2 | 0.7 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.2 | 1.8 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 0.5 | GO:0061010 | gall bladder development(GO:0061010) |
0.2 | 0.4 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.2 | 0.2 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.2 | 4.2 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 1.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.2 | 0.2 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.2 | 0.4 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.2 | 4.2 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.2 | 2.2 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.2 | 0.7 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 0.2 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.2 | 0.5 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.2 | 0.4 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.2 | 1.6 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.2 | 1.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 0.9 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.2 | 0.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.2 | 0.9 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.2 | 2.8 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.2 | 0.9 | GO:0015671 | oxygen transport(GO:0015671) |
0.2 | 0.5 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.2 | 0.7 | GO:0032908 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
0.2 | 0.4 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.2 | 0.4 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.2 | 0.7 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 0.5 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 0.2 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.2 | 0.3 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.2 | 0.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 0.3 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.2 | 0.5 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.2 | 0.7 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.2 | 1.4 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.2 | 0.5 | GO:0051256 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.2 | 0.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.2 | 2.7 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.2 | 1.2 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.2 | 2.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 0.5 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.2 | 2.2 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.2 | 0.2 | GO:0046102 | inosine metabolic process(GO:0046102) inosine biosynthetic process(GO:0046103) |
0.2 | 0.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 | 0.7 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.2 | 1.8 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.2 | 0.2 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.2 | 0.8 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.2 | 0.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.2 | 1.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 1.3 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 2.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.2 | 1.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.2 | 0.5 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 0.2 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.2 | 0.5 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.2 | 1.1 | GO:0060613 | fat pad development(GO:0060613) |
0.2 | 0.2 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.2 | 0.3 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
0.2 | 1.3 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.2 | 1.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.2 | 0.5 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.2 | 0.8 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 2.2 | GO:0043471 | regulation of carbohydrate catabolic process(GO:0043470) regulation of cellular carbohydrate catabolic process(GO:0043471) |
0.2 | 3.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 | 1.1 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.2 | 0.5 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.2 | 0.5 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.2 | 0.2 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.2 | 0.6 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.2 | 0.5 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.2 | 0.3 | GO:0072413 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.2 | 1.3 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.2 | 0.3 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.2 | 0.9 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.2 | 0.3 | GO:0034033 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.2 | 4.1 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.2 | 0.3 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.2 | 0.3 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
0.2 | 0.6 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.2 | 1.3 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.2 | 0.6 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 0.2 | GO:0010998 | regulation of translational initiation by eIF2 alpha phosphorylation(GO:0010998) |
0.2 | 0.6 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 0.6 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.2 | 1.1 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.2 | 0.5 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.2 | 0.3 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.2 | 4.2 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.2 | 0.6 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.2 | 0.5 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.2 | 0.5 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.2 | 0.3 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.2 | 0.3 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.2 | 1.7 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.2 | 0.2 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.2 | 0.5 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.2 | 0.5 | GO:0061511 | centriole elongation(GO:0061511) |
0.2 | 0.5 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.2 | 1.8 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.2 | 0.5 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.2 | 1.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.2 | 0.3 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.2 | 3.0 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.2 | 0.9 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.1 | 1.6 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.1 | 0.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.6 | GO:0015867 | ATP transport(GO:0015867) |
0.1 | 2.2 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.4 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.3 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.1 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.1 | 0.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.1 | 0.7 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.1 | 0.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.3 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.1 | 0.4 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.1 | 2.2 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.3 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.3 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 1.2 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.7 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.1 | 0.6 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 1.0 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 0.7 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 1.2 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.1 | 1.3 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 0.6 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.1 | 0.7 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 1.0 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.4 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.1 | 0.6 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 0.6 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 0.7 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.1 | 0.6 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.1 | 0.1 | GO:0042851 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
0.1 | 0.4 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.7 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.4 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.6 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.7 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.1 | 0.6 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.1 | 0.6 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.1 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.1 | 0.3 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.5 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.1 | 0.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.8 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.5 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.1 | 0.5 | GO:0009415 | response to water(GO:0009415) |
0.1 | 1.1 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 0.3 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.1 | 1.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.1 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.1 | 5.2 | GO:0030168 | platelet activation(GO:0030168) |
0.1 | 1.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.5 | GO:0051031 | tRNA transport(GO:0051031) |
0.1 | 0.1 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.1 | 0.3 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.1 | 0.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.7 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 1.2 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.1 | 1.4 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.1 | GO:0018904 | ether metabolic process(GO:0018904) |
0.1 | 2.0 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 1.7 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 0.8 | GO:0052803 | histidine metabolic process(GO:0006547) imidazole-containing compound metabolic process(GO:0052803) |
0.1 | 0.8 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.7 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.4 | GO:0042148 | strand invasion(GO:0042148) |
0.1 | 0.5 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.4 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 0.9 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.1 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.1 | 0.4 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 1.7 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.1 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.1 | 0.3 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.1 | 2.1 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 1.6 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.1 | 0.4 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.7 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) |
0.1 | 0.5 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.1 | GO:0032762 | mast cell cytokine production(GO:0032762) regulation of mast cell cytokine production(GO:0032763) |
0.1 | 0.3 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 2.9 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.1 | 0.4 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.7 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.5 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.1 | 0.7 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.8 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 0.5 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.1 | 0.1 | GO:0003032 | detection of oxygen(GO:0003032) |
0.1 | 0.6 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.3 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 0.3 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 0.6 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.1 | 0.4 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.1 | GO:0006101 | citrate metabolic process(GO:0006101) |
0.1 | 0.5 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.4 | GO:0051029 | rRNA transport(GO:0051029) |
0.1 | 0.8 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 0.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 4.8 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.4 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.1 | 0.6 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.1 | 0.1 | GO:0018158 | protein oxidation(GO:0018158) |
0.1 | 0.1 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.1 | 0.7 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 2.1 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 0.1 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.4 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 1.5 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.1 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.1 | 0.5 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.2 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.4 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 0.9 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.1 | 0.6 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 1.1 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.9 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.1 | 0.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 1.6 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.2 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.1 | 1.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.2 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.1 | 0.1 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 9.9 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.1 | 0.1 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.1 | 0.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 1.3 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.1 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.1 | 1.3 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.1 | 1.0 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 0.7 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.6 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.1 | 0.8 | GO:0010863 | positive regulation of phospholipase C activity(GO:0010863) |
0.1 | 0.4 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.1 | 0.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.5 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.1 | 0.1 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.1 | 0.7 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.7 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.6 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.6 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.1 | 0.4 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.1 | 0.7 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.1 | 0.2 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.9 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.9 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.1 | 0.3 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.1 | 0.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.2 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.1 | 0.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.8 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.1 | 0.5 | GO:0051299 | centrosome separation(GO:0051299) |
0.1 | 0.6 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.3 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.7 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.1 | 0.2 | GO:1901341 | positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 0.1 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.1 | 0.2 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.1 | 0.3 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.1 | 0.2 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.1 | 0.2 | GO:0002155 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.1 | 0.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 0.1 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.1 | 0.8 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.2 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.9 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 1.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.1 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.1 | 0.1 | GO:0070384 | Harderian gland development(GO:0070384) |
0.1 | 0.3 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 2.4 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.5 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.1 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.1 | 0.9 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.1 | 0.3 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 | 0.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.4 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.5 | GO:0032782 | bile acid secretion(GO:0032782) |
0.1 | 0.5 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.1 | 1.4 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.2 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.4 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.1 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.1 | 1.0 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.1 | 0.2 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 0.1 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.1 | 0.1 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.1 | 1.7 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.2 | GO:0002432 | granuloma formation(GO:0002432) |
0.1 | 0.1 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 0.6 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.1 | 0.1 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.1 | 0.4 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.5 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.5 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 0.1 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.1 | 0.5 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.4 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.1 | 4.1 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.4 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.4 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 3.2 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.1 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.3 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.1 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.1 | 1.4 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.1 | 0.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 0.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.7 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.1 | 1.1 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.5 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.1 | 0.5 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.6 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.9 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.3 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.4 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.5 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.1 | 1.0 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.1 | 0.7 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.1 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.1 | 1.6 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.4 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 0.5 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.4 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.3 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.2 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.1 | 0.2 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 1.6 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.1 | 0.8 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.1 | 0.2 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 | 0.2 | GO:0006311 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.1 | 0.3 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.2 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 0.1 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 0.1 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.1 | 0.4 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.3 | GO:1901679 | pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
0.1 | 0.3 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.6 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 0.6 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.1 | 0.4 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.4 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.1 | 0.2 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.4 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 1.9 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.3 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.1 | 0.3 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.2 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.1 | 0.3 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.1 | 0.2 | GO:0048143 | astrocyte activation(GO:0048143) |
0.1 | 0.7 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 1.4 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.5 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.2 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 1.9 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.2 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.1 | 0.4 | GO:0030575 | nuclear body organization(GO:0030575) |
0.1 | 3.6 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.1 | 1.4 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 1.8 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.1 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 0.3 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.1 | 0.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.4 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.8 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.3 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.1 | 0.1 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.1 | 0.2 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.1 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.1 | 0.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.7 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.1 | 0.1 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
0.1 | 0.7 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.1 | 0.2 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.9 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.4 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.1 | 0.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.1 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.1 | 0.4 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.2 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.1 | 0.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 0.7 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.5 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 0.3 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 0.3 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.6 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.6 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.3 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 0.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 1.0 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.1 | 0.5 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.1 | 0.6 | GO:0044247 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 0.2 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.8 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.1 | 1.0 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.1 | 0.2 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.1 | 0.2 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.1 | 0.3 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.2 | GO:0048241 | epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) |
0.1 | 0.2 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.1 | 0.2 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 0.2 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.7 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 1.1 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.7 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.2 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.1 | 0.3 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 0.2 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.3 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.4 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.2 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.1 | 0.1 | GO:0072401 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.1 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 | 1.4 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.5 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.1 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.1 | 0.4 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.1 | 0.3 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 0.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.3 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.1 | 0.1 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.1 | 0.3 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.1 | 0.2 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.1 | 0.4 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.1 | 0.2 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.1 | 0.1 | GO:1903671 | negative regulation of sprouting angiogenesis(GO:1903671) |
0.1 | 0.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.1 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.1 | 0.4 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.2 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 0.4 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 0.1 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.1 | 0.1 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.1 | 0.1 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 0.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.8 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.1 | 0.2 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 0.3 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.7 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 0.1 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 0.2 | GO:0043039 | tRNA aminoacylation(GO:0043039) |
0.1 | 0.2 | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
0.1 | 0.7 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.2 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.1 | 0.9 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.1 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.1 | GO:0006188 | IMP biosynthetic process(GO:0006188) |
0.1 | 0.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.1 | 0.2 | GO:0009204 | deoxyribonucleoside triphosphate catabolic process(GO:0009204) |
0.1 | 0.7 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.1 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.1 | 0.2 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.1 | 0.9 | GO:0007094 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.1 | 0.9 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.8 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.7 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 0.1 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.1 | 0.6 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 0.5 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
0.1 | 0.4 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.1 | 2.6 | GO:0007599 | hemostasis(GO:0007599) |
0.1 | 0.8 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.1 | 0.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.1 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.1 | 0.1 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.1 | 0.1 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.1 | 0.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.1 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 0.1 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.1 | 0.2 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.1 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 0.3 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.6 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 1.2 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 | 0.3 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.5 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.1 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.1 | 0.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 1.5 | GO:0009060 | aerobic respiration(GO:0009060) |
0.1 | 1.4 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.5 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 0.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.2 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.1 | GO:0032205 | negative regulation of telomere maintenance(GO:0032205) |
0.1 | 0.1 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.1 | 0.3 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.1 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.1 | 0.1 | GO:0010421 | hydrogen peroxide-mediated programmed cell death(GO:0010421) programmed cell death in response to reactive oxygen species(GO:0097468) |
0.1 | 0.3 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.1 | 0.4 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.2 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.1 | 0.2 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.1 | 0.3 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 1.8 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 0.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.1 | GO:1905063 | regulation of vascular smooth muscle cell differentiation(GO:1905063) |
0.1 | 1.2 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.1 | 0.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.1 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.1 | 0.2 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.1 | 0.1 | GO:0001828 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
0.1 | 0.1 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 1.2 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.1 | 0.1 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.1 | 0.3 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.1 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.1 | 0.1 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.1 | 1.4 | GO:0032873 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.1 | 0.1 | GO:0034310 | ethanol catabolic process(GO:0006068) primary alcohol catabolic process(GO:0034310) |
0.1 | 0.1 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.1 | 1.2 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 1.3 | GO:0032355 | response to estradiol(GO:0032355) |
0.1 | 3.0 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.1 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.1 | GO:0002885 | positive regulation of hypersensitivity(GO:0002885) |
0.1 | 0.3 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.2 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.1 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.1 | 0.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.3 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.1 | 0.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 0.1 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.1 | 0.2 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.1 | 0.5 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.1 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.1 | 0.2 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 0.2 | GO:0035813 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.1 | 0.1 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.1 | 0.2 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.5 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.1 | 0.2 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.8 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 0.1 | GO:0033083 | regulation of immature T cell proliferation(GO:0033083) |
0.1 | 0.1 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.1 | 0.2 | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.1 | 1.3 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.1 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.3 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.1 | 0.8 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.2 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.1 | 0.1 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.1 | 0.2 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.2 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.1 | 0.1 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.1 | 0.3 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.1 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.1 | 0.2 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.1 | 0.6 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 1.5 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 0.1 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 0.3 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.1 | 0.3 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.4 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.1 | 0.1 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
0.1 | 0.3 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.1 | 0.2 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.1 | 0.5 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.1 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.1 | 0.2 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.1 | 0.2 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.1 | 0.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 2.8 | GO:0032869 | cellular response to insulin stimulus(GO:0032869) |
0.1 | 0.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.5 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.8 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 1.9 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.1 | 0.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.1 | 0.1 | GO:0000305 | response to superoxide(GO:0000303) response to oxygen radical(GO:0000305) |
0.1 | 0.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 0.2 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.1 | 0.2 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.4 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.1 | 0.1 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.1 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 0.1 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.1 | 0.4 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.1 | 0.2 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.7 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.2 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 0.2 | GO:1902745 | positive regulation of lamellipodium organization(GO:1902745) |
0.1 | 0.4 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 1.3 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.1 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.1 | 0.1 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.1 | 0.1 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.1 | 0.2 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 2.0 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 0.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.1 | 0.4 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 0.1 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.3 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 0.1 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.0 | 0.1 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.1 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 1.2 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.0 | 0.2 | GO:0032392 | DNA geometric change(GO:0032392) |
0.0 | 0.0 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.0 | 0.0 | GO:0046271 | phenylpropanoid metabolic process(GO:0009698) phenylpropanoid catabolic process(GO:0046271) |
0.0 | 0.3 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.0 | 0.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.0 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.0 | 0.1 | GO:0044351 | macropinocytosis(GO:0044351) |
0.0 | 0.0 | GO:1904356 | regulation of telomere maintenance via telomere lengthening(GO:1904356) |
0.0 | 0.2 | GO:0055026 | negative regulation of cardiac muscle tissue development(GO:0055026) |
0.0 | 0.2 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.0 | 0.8 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.1 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
0.0 | 0.5 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.4 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 0.1 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.0 | 0.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 1.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.1 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.0 | 0.7 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.0 | 0.1 | GO:0044116 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
0.0 | 4.1 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.0 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.0 | 0.2 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.0 | 0.1 | GO:0034405 | response to fluid shear stress(GO:0034405) |
0.0 | 0.3 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.3 | GO:0032967 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.0 | 0.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.0 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.0 | 0.2 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.0 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.0 | 0.4 | GO:0034204 | lipid translocation(GO:0034204) |
0.0 | 0.2 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
0.0 | 0.0 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.0 | 0.4 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.0 | 0.3 | GO:0031297 | replication fork processing(GO:0031297) |
0.0 | 0.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.2 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.1 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 1.0 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.8 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
0.0 | 0.0 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 1.8 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.5 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.0 | 0.4 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.0 | 0.1 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.0 | 0.0 | GO:0010888 | negative regulation of lipid storage(GO:0010888) |
0.0 | 0.0 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.0 | 0.3 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.0 | 0.5 | GO:0002279 | mast cell activation involved in immune response(GO:0002279) mast cell mediated immunity(GO:0002448) mast cell degranulation(GO:0043303) |
0.0 | 0.1 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.0 | 0.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.0 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.0 | 0.1 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.0 | 0.3 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.5 | GO:1904029 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.0 | 0.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.0 | 0.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.4 | GO:0046463 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.0 | 0.1 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.0 | 0.3 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.0 | 0.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.0 | 0.0 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.2 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.0 | 0.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.1 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
0.0 | 0.2 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.0 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.5 | GO:0035690 | cellular response to drug(GO:0035690) |
0.0 | 0.6 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.1 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 | 0.0 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.1 | GO:0044845 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.0 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.1 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.0 | 0.1 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.0 | 1.0 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.0 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.0 | 0.4 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.0 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.0 | 0.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.0 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.0 | 0.1 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.0 | 0.1 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.0 | 0.2 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.0 | 0.1 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.0 | 0.0 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.0 | 0.5 | GO:0044042 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.0 | 0.3 | GO:0015893 | drug transport(GO:0015893) |
0.0 | 0.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.0 | GO:0051352 | negative regulation of ligase activity(GO:0051352) |
0.0 | 0.1 | GO:0051797 | regulation of hair follicle development(GO:0051797) negative regulation of hair follicle development(GO:0051799) |
0.0 | 0.5 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.0 | GO:0044788 | modulation by host of viral process(GO:0044788) |
0.0 | 0.0 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.0 | 0.7 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.0 | 0.1 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.0 | 0.1 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.0 | 0.0 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.0 | 0.1 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.0 | 0.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.0 | 0.3 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.1 | GO:0046931 | pore complex assembly(GO:0046931) |
0.0 | 0.4 | GO:0051972 | regulation of telomerase activity(GO:0051972) |
0.0 | 0.1 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.0 | 0.0 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.0 | 0.7 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.0 | 0.3 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.0 | GO:0002830 | positive regulation of type 2 immune response(GO:0002830) |
0.0 | 0.1 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.0 | 0.2 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.1 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.3 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.1 | GO:0015677 | copper ion import(GO:0015677) |
0.0 | 0.2 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.0 | 0.0 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.0 | 0.2 | GO:0019614 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.0 | 0.3 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.0 | 0.0 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.0 | 0.1 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.0 | 0.2 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.1 | GO:0090071 | regulation of ribosome biogenesis(GO:0090069) negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 0.4 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.0 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.2 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.0 | 0.1 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 0.0 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.0 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.0 | 0.0 | GO:0008050 | female courtship behavior(GO:0008050) |
0.0 | 0.5 | GO:0007569 | cell aging(GO:0007569) |
0.0 | 0.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.0 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.0 | 0.4 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.0 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.0 | 0.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.0 | 0.2 | GO:0099587 | inorganic cation import into cell(GO:0098659) inorganic ion import into cell(GO:0099587) |
0.0 | 0.1 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.1 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.3 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.0 | 0.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.1 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.5 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.2 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.0 | 0.1 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.1 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.0 | 0.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.0 | 0.0 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.0 | 0.1 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.0 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.0 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.0 | 0.1 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.0 | 0.0 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.1 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.0 | 0.1 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.1 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.0 | 0.4 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.0 | 0.4 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 0.6 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.0 | 0.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.0 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.0 | 0.2 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.0 | 0.2 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.0 | 0.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.2 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.0 | 0.6 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.0 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.0 | 0.0 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.0 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.0 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.0 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.0 | 0.1 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.0 | 0.0 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 0.1 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.0 | 0.0 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.0 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.0 | 0.1 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.0 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.0 | 0.0 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.0 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.0 | 0.4 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.1 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.0 | 0.1 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.0 | 0.0 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.0 | 0.2 | GO:0051168 | nuclear export(GO:0051168) |
0.0 | 0.3 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.0 | 0.1 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.0 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.0 | 0.0 | GO:0097286 | iron ion import(GO:0097286) |
0.0 | 0.0 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.0 | 0.1 | GO:0045924 | regulation of female receptivity(GO:0045924) |
0.0 | 0.1 | GO:0030220 | platelet formation(GO:0030220) |
0.0 | 0.1 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.0 | 0.1 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.0 | 0.5 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.0 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.0 | 0.0 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.0 | GO:0051196 | regulation of cofactor metabolic process(GO:0051193) regulation of coenzyme metabolic process(GO:0051196) |
0.0 | 0.0 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) |
0.0 | 0.0 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.0 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.0 | 0.2 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.0 | 0.0 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.0 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.0 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.0 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.0 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.0 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.0 | 0.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.0 | 0.0 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.0 | 0.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.1 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.0 | 0.0 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.0 | 0.0 | GO:1903624 | regulation of DNA catabolic process(GO:1903624) |
0.0 | 0.0 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.0 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.0 | 0.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.0 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.0 | 0.0 | GO:0046851 | negative regulation of bone remodeling(GO:0046851) |
0.0 | 0.1 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.0 | GO:0001993 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) |
0.0 | 0.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.0 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 1.5 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.0 | 0.0 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
0.0 | 0.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.3 | GO:0052696 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.0 | 0.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.0 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 0.0 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.0 | 0.1 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.0 | 0.1 | GO:1902117 | positive regulation of organelle assembly(GO:1902117) |
0.0 | 0.1 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 0.0 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.0 | GO:0043174 | nucleoside salvage(GO:0043174) |
0.0 | 0.1 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.0 | 0.1 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.0 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.0 | 0.0 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.0 | 0.0 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.0 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.1 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.0 | 0.1 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.0 | 0.1 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.0 | 0.0 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.0 | 0.0 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.0 | 0.0 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.0 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) |
0.0 | 0.0 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.0 | 0.0 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.0 | 0.0 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.0 | 0.0 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.0 | 0.0 | GO:0044062 | regulation of excretion(GO:0044062) |
0.0 | 0.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.0 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.0 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.0 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 0.0 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.0 | 0.1 | GO:1903901 | negative regulation of viral life cycle(GO:1903901) |
0.0 | 0.1 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.0 | 0.5 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.0 | 0.2 | GO:0060389 | pathway-restricted SMAD protein phosphorylation(GO:0060389) |
0.0 | 0.0 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 0.0 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.0 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.0 | 0.0 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.0 | 0.1 | GO:0009303 | rRNA transcription(GO:0009303) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 13.7 | GO:0031430 | M band(GO:0031430) |
0.7 | 3.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.7 | 2.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.7 | 2.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.6 | 2.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.6 | 2.5 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.6 | 1.8 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.6 | 1.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.6 | 3.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.6 | 2.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.6 | 5.0 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.5 | 2.5 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.5 | 4.9 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.5 | 1.4 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.4 | 1.7 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.4 | 3.5 | GO:0042587 | glycogen granule(GO:0042587) |
0.4 | 2.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.4 | 1.2 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.4 | 1.2 | GO:1990423 | RZZ complex(GO:1990423) |
0.4 | 0.8 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.4 | 1.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.4 | 1.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.4 | 0.8 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.4 | 3.0 | GO:0005861 | troponin complex(GO:0005861) |
0.4 | 1.9 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.4 | 1.1 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.4 | 1.5 | GO:0072487 | MSL complex(GO:0072487) |
0.4 | 1.1 | GO:0031523 | Myb complex(GO:0031523) |
0.4 | 2.9 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.4 | 1.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.4 | 6.3 | GO:0002102 | podosome(GO:0002102) |
0.4 | 0.7 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.3 | 1.0 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.3 | 1.3 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.3 | 1.0 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.3 | 2.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 2.3 | GO:0005652 | nuclear lamina(GO:0005652) |
0.3 | 1.3 | GO:0035363 | histone locus body(GO:0035363) |
0.3 | 1.9 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.3 | 0.9 | GO:0097443 | sorting endosome(GO:0097443) |
0.3 | 0.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.3 | 4.8 | GO:0043034 | costamere(GO:0043034) |
0.3 | 3.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.3 | 1.2 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.3 | 0.9 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 0.9 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.3 | 1.1 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.3 | 2.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 3.3 | GO:0016460 | myosin II complex(GO:0016460) |
0.3 | 1.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.3 | 1.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.3 | 1.1 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.3 | 1.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.3 | 1.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.3 | 0.8 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.3 | 1.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.3 | 4.3 | GO:0031672 | A band(GO:0031672) |
0.3 | 2.0 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.3 | 11.6 | GO:0014704 | intercalated disc(GO:0014704) |
0.2 | 1.0 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.2 | 0.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.2 | 1.5 | GO:1990462 | omegasome(GO:1990462) |
0.2 | 2.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 9.0 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 1.0 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.2 | 2.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 1.0 | GO:0005642 | annulate lamellae(GO:0005642) |
0.2 | 1.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 0.9 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 0.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 1.6 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 0.7 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.2 | 1.4 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 0.5 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 0.9 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.2 | 0.7 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.2 | 0.5 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.2 | 0.2 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.2 | 0.9 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 2.0 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 3.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.2 | 0.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 1.5 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 7.9 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 1.7 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.2 | 0.6 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.2 | 0.4 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 2.5 | GO:0042581 | specific granule(GO:0042581) |
0.2 | 2.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 1.0 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.2 | 0.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.2 | 1.0 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 1.4 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 0.6 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.2 | 1.2 | GO:0005818 | aster(GO:0005818) |
0.2 | 1.0 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 5.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 1.0 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 0.4 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.2 | 1.3 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 1.7 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 1.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 13.5 | GO:0030017 | sarcomere(GO:0030017) |
0.2 | 0.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 7.7 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.2 | 1.2 | GO:0071546 | pi-body(GO:0071546) |
0.2 | 0.7 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 0.7 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.2 | 1.9 | GO:0016580 | Sin3 complex(GO:0016580) |
0.2 | 0.5 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 0.5 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.2 | 2.2 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.2 | 0.3 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 0.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 0.5 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.2 | 1.5 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.2 | 0.5 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 0.5 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 1.3 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 0.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 1.9 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.2 | 0.3 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.2 | 1.9 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 1.0 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 2.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 1.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 0.8 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 0.8 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.2 | 0.8 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.2 | 2.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 0.6 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 0.5 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.2 | 0.6 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 1.2 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 3.9 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 1.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.3 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.1 | 2.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 7.7 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.4 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.1 | 0.4 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 2.9 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.9 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 2.4 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.7 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.1 | 2.6 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 1.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 4.8 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 0.1 | GO:0044391 | ribosomal subunit(GO:0044391) |
0.1 | 0.8 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 1.2 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 0.7 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.4 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.1 | 0.1 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 1.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.3 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.4 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 1.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.9 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.7 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 0.3 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 2.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.8 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.8 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 1.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 1.9 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.5 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.5 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 1.0 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 0.9 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 1.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 2.9 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 1.1 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 0.9 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 3.2 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 0.7 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 4.5 | GO:0042383 | sarcolemma(GO:0042383) |
0.1 | 0.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.9 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.9 | GO:0001939 | female pronucleus(GO:0001939) |
0.1 | 0.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 1.9 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.8 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.2 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 1.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 1.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.4 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.4 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 4.6 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 0.2 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 1.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.9 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.5 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.9 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.7 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.5 | GO:0001652 | granular component(GO:0001652) |
0.1 | 9.1 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.8 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.3 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.1 | 0.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 27.6 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 0.6 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 0.4 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 3.4 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 1.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.3 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.6 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 0.2 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 1.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.9 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.2 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 0.3 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 1.4 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 0.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.5 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 3.2 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 1.2 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.9 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 1.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.3 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 0.5 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 0.7 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.6 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.5 | GO:0061702 | inflammasome complex(GO:0061702) |
0.1 | 0.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 1.6 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 0.4 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 1.4 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 2.8 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.2 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 1.9 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 1.4 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 1.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 2.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.3 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 10.6 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 0.4 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 7.0 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 3.2 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 4.1 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.3 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.4 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.5 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 0.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 2.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 1.4 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.6 | GO:0034719 | SMN complex(GO:0032797) SMN-Sm protein complex(GO:0034719) |
0.1 | 5.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.6 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 0.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 0.3 | GO:0070187 | telosome(GO:0070187) |
0.1 | 0.7 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.2 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.9 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.6 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 2.8 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 2.5 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.6 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.9 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 0.2 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 0.9 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 0.3 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.7 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.4 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.2 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.1 | 3.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 3.1 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 2.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 1.0 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.3 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 17.2 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 0.4 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.8 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 0.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.4 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.3 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 66.9 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.9 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 0.5 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 0.2 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 0.7 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.9 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.5 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.9 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 6.5 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 0.1 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 0.1 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.1 | 0.3 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.3 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.4 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.1 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.1 | 0.4 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 0.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 0.2 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 0.1 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 0.3 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 2.2 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 7.7 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 0.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 2.5 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 0.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.4 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 2.7 | GO:0005938 | cell cortex(GO:0005938) |
0.1 | 0.7 | GO:0005819 | spindle(GO:0005819) |
0.1 | 1.3 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.4 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 1.5 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.3 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.2 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 0.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 0.8 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.1 | GO:0072534 | perineuronal net(GO:0072534) |
0.0 | 1.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.4 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 4.8 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.0 | 0.2 | GO:0031968 | organelle outer membrane(GO:0031968) |
0.0 | 0.2 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 2.3 | GO:0036126 | sperm flagellum(GO:0036126) |
0.0 | 0.9 | GO:1902493 | protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.0 | 30.4 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 0.0 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.2 | GO:0036452 | ESCRT complex(GO:0036452) |
0.0 | 2.9 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.1 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 1.8 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.7 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.0 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.0 | 0.0 | GO:0033269 | internode region of axon(GO:0033269) |
0.0 | 0.6 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.1 | GO:0005914 | spot adherens junction(GO:0005914) |
0.0 | 2.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.0 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.0 | 1.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.4 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.3 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.1 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.0 | 0.1 | GO:0043219 | lateral loop(GO:0043219) |
0.0 | 5.5 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 0.3 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.5 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 4.0 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 1.4 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 0.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.0 | GO:0044393 | microspike(GO:0044393) |
0.0 | 0.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 2.8 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.3 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.1 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.0 | 0.0 | GO:0043205 | fibril(GO:0043205) |
0.0 | 0.1 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.5 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.7 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.0 | 0.6 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.0 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 24.9 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 0.0 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 1.8 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.0 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.0 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.1 | GO:0030894 | replisome(GO:0030894) |
0.0 | 0.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.0 | 0.0 | GO:0031261 | GINS complex(GO:0000811) DNA replication preinitiation complex(GO:0031261) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 5.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.4 | 5.5 | GO:0031433 | telethonin binding(GO:0031433) |
1.2 | 3.7 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.1 | 1.1 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
1.0 | 4.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.0 | 2.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.9 | 2.8 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.9 | 2.7 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.8 | 2.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.8 | 0.8 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.8 | 3.9 | GO:0071253 | connexin binding(GO:0071253) |
0.7 | 0.7 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.7 | 2.0 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.7 | 3.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.7 | 2.6 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.6 | 3.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.6 | 1.9 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.6 | 3.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.6 | 2.5 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.6 | 2.5 | GO:0042731 | PH domain binding(GO:0042731) |
0.6 | 1.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.6 | 3.5 | GO:0004064 | arylesterase activity(GO:0004064) |
0.5 | 2.7 | GO:0031013 | troponin I binding(GO:0031013) |
0.5 | 1.6 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.5 | 1.5 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.5 | 2.0 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.5 | 2.9 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.5 | 2.9 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.5 | 1.9 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.5 | 1.9 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.5 | 1.4 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.5 | 1.4 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.5 | 1.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.4 | 1.3 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.4 | 2.2 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.4 | 1.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.4 | 2.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.4 | 0.4 | GO:0043426 | MRF binding(GO:0043426) |
0.4 | 1.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.4 | 1.3 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.4 | 1.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.4 | 2.5 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.4 | 1.2 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.4 | 2.0 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.4 | 1.6 | GO:0015265 | urea channel activity(GO:0015265) |
0.4 | 1.2 | GO:0055100 | adiponectin binding(GO:0055100) |
0.4 | 0.8 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.4 | 1.2 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.4 | 1.2 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.4 | 1.6 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.4 | 3.2 | GO:0034046 | poly(G) binding(GO:0034046) |
0.4 | 2.7 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.4 | 1.5 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.4 | 2.7 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.4 | 1.5 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.4 | 2.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.4 | 1.9 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.4 | 1.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.4 | 0.4 | GO:0019808 | polyamine binding(GO:0019808) |
0.4 | 1.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.4 | 1.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.4 | 1.8 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.4 | 1.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.4 | 1.1 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.4 | 2.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.4 | 0.7 | GO:0035877 | death effector domain binding(GO:0035877) |
0.4 | 1.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.4 | 1.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 1.7 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.3 | 2.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.3 | 1.0 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.3 | 1.0 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.3 | 1.0 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.3 | 1.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.3 | 1.0 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.3 | 1.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.3 | 1.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 2.3 | GO:0031432 | titin binding(GO:0031432) |
0.3 | 2.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 2.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.3 | 1.3 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.3 | 0.9 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.3 | 2.2 | GO:0003896 | DNA primase activity(GO:0003896) |
0.3 | 0.6 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.3 | 7.7 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.3 | 1.5 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.3 | 0.6 | GO:0004096 | catalase activity(GO:0004096) |
0.3 | 1.2 | GO:0009374 | biotin binding(GO:0009374) |
0.3 | 1.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.3 | 0.9 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.3 | 1.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 3.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.3 | 1.2 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.3 | 1.5 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.3 | 0.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.3 | 0.9 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.3 | 1.1 | GO:0043723 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.3 | 0.6 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.3 | 0.3 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.3 | 1.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.3 | 4.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.3 | 3.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.3 | 0.8 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.3 | 1.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.3 | 1.9 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.3 | 0.8 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.3 | 1.9 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.3 | 2.8 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.3 | 1.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.3 | 0.8 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.3 | 3.8 | GO:0005521 | lamin binding(GO:0005521) |
0.3 | 1.4 | GO:0070728 | leucine binding(GO:0070728) |
0.3 | 1.9 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.3 | 3.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 0.8 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.3 | 1.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.3 | 0.8 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.3 | 2.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 0.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.3 | 2.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 0.8 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.3 | 1.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 4.9 | GO:0001848 | complement binding(GO:0001848) |
0.3 | 2.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.3 | 2.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.3 | 5.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.3 | 0.5 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.3 | 0.8 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.3 | 2.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 6.2 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.2 | 0.7 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 2.7 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 1.0 | GO:0036033 | mediator complex binding(GO:0036033) |
0.2 | 0.7 | GO:0030984 | kininogen binding(GO:0030984) |
0.2 | 2.4 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 0.9 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 1.4 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.2 | 1.9 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.2 | 0.9 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.2 | 0.7 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.2 | 0.7 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 0.7 | GO:0035939 | microsatellite binding(GO:0035939) |
0.2 | 0.7 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.2 | 1.1 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.2 | 1.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.2 | 0.7 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.2 | 0.7 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.2 | 0.4 | GO:0030519 | snoRNP binding(GO:0030519) |
0.2 | 0.7 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.2 | 0.9 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 0.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 1.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.2 | 0.7 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 1.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.2 | 1.3 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.2 | 1.1 | GO:0035473 | lipase binding(GO:0035473) |
0.2 | 0.7 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.2 | 0.7 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 1.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 1.7 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 1.5 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.2 | 0.6 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.2 | 0.9 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.2 | 1.1 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 0.6 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 0.6 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 1.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 1.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.2 | 0.8 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.2 | 2.3 | GO:0060229 | lipase activator activity(GO:0060229) |
0.2 | 0.4 | GO:0019961 | interferon binding(GO:0019961) |
0.2 | 0.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 0.4 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.2 | 3.1 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.2 | 0.6 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 0.4 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.2 | 0.8 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 1.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 3.7 | GO:0071949 | FAD binding(GO:0071949) |
0.2 | 0.8 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 0.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 0.4 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.2 | 1.2 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.2 | 0.6 | GO:2001070 | starch binding(GO:2001070) |
0.2 | 1.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 0.4 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.2 | 0.6 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.2 | 0.6 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.2 | 0.4 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.2 | 0.6 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 3.6 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.2 | 0.6 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 0.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.2 | 1.2 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.2 | 0.8 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.2 | 0.6 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.2 | 5.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 1.8 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 1.0 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.2 | 2.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 3.6 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 1.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 0.6 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.2 | 0.6 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.2 | 0.8 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.2 | 1.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 0.8 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 2.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 0.7 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 2.2 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.2 | 0.7 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.2 | 0.7 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 0.6 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.2 | 0.4 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.2 | 0.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.2 | 0.9 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.2 | 0.7 | GO:0043559 | insulin binding(GO:0043559) |
0.2 | 1.1 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 4.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.2 | 0.5 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.2 | 0.5 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.2 | 2.0 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 0.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.2 | 0.9 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 0.2 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.2 | 0.5 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.2 | 0.5 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.2 | 0.9 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.2 | 0.7 | GO:0035173 | histone kinase activity(GO:0035173) |
0.2 | 0.7 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.2 | 0.2 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 2.4 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.2 | 0.2 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.2 | 3.8 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.2 | 0.7 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 1.6 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.2 | 0.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 0.3 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.2 | 0.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 0.2 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.2 | 0.3 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.2 | 2.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.7 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.2 | 1.0 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 0.5 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.2 | 0.3 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.2 | 2.2 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 1.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 4.0 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 1.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 0.8 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 0.7 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 0.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 0.5 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.2 | 2.5 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 0.5 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.2 | 4.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 8.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.2 | 1.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 8.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 0.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 0.5 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 0.8 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 0.9 | GO:0034809 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.2 | 6.6 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 0.3 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.2 | 0.6 | GO:0015266 | protein channel activity(GO:0015266) |
0.2 | 1.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 1.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.2 | 0.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.9 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 0.3 | GO:0045340 | mercury ion binding(GO:0045340) |
0.2 | 10.8 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.2 | 0.6 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.2 | 3.2 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.2 | 1.5 | GO:0004787 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.2 | 0.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 0.5 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 0.5 | GO:0018593 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.2 | 0.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 0.5 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.1 | 0.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 1.6 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 2.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.3 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 1.8 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.7 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.1 | 0.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.9 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.1 | 0.4 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.1 | 0.6 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.6 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 0.4 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.9 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.6 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 2.0 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.1 | 1.4 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 4.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.7 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 1.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.5 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 0.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 1.9 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.5 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.9 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.1 | 0.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.8 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.9 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.5 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.8 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 2.5 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 0.4 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.1 | 0.1 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.1 | 0.7 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.1 | 0.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.4 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 2.5 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.3 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.1 | 0.4 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.6 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.4 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 0.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 0.5 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.3 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.1 | 0.8 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.4 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.1 | 0.9 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.5 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.6 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 0.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 0.7 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 7.7 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.1 | 2.7 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.1 | 0.7 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 0.5 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.6 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.6 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 2.4 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 0.5 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 4.1 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.4 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 1.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 0.5 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.1 | 0.4 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 2.6 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.1 | 0.5 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.1 | 0.5 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 0.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 5.9 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.1 | 1.9 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.9 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 1.0 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.6 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 2.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 1.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.6 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 0.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.2 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 3.5 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.1 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.2 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.1 | 0.6 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.3 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.8 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.2 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.3 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.1 | 0.3 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 20.9 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 3.3 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 2.2 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.2 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 1.9 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.1 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 1.6 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.1 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.1 | 0.3 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.9 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 1.3 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 0.7 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 1.1 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 1.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.5 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 0.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) guanylyltransferase activity(GO:0070568) |
0.1 | 0.3 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.1 | 0.3 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 0.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 1.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.3 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 2.2 | GO:0004119 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.1 | 1.8 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 0.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 0.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.7 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.5 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.2 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 0.3 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.1 | 0.5 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.1 | 0.2 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.4 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.4 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 0.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 2.6 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 3.0 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.1 | 5.0 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 1.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.5 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.1 | 0.4 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.5 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.5 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.1 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.1 | 6.1 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.9 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 1.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.1 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.1 | 1.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.4 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.1 | 0.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.4 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.4 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.2 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.1 | 0.8 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 0.2 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 0.2 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 1.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.2 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 3.0 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.3 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.6 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.6 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.2 | GO:0032138 | DNA insertion or deletion binding(GO:0032135) single base insertion or deletion binding(GO:0032138) |
0.1 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 1.0 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 1.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.2 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 0.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.2 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 3.2 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 0.1 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.1 | 0.4 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.2 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.1 | 0.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.4 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 0.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.2 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.4 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.9 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 0.2 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.1 | 0.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 0.7 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 11.0 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.1 | 0.6 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.1 | 1.6 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 0.6 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.5 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 0.6 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.2 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.4 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.1 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 11.0 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 0.2 | GO:0048030 | disaccharide binding(GO:0048030) |
0.1 | 1.7 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.1 | 0.4 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.1 | 0.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 0.1 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 0.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 0.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.6 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.1 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.1 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 0.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 2.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.3 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.6 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.2 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.5 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 2.3 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.1 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.1 | 0.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 1.3 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.3 | GO:0005048 | signal sequence binding(GO:0005048) |
0.1 | 0.3 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 1.7 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 0.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.8 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.5 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.8 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 0.6 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 2.0 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 0.3 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 0.2 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 2.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.2 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.1 | 0.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.1 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.1 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.6 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 0.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.6 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.1 | 0.4 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 1.6 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.2 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) |
0.1 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 2.0 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 1.3 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
0.1 | 1.7 | GO:0016903 | oxidoreductase activity, acting on the aldehyde or oxo group of donors(GO:0016903) |
0.1 | 0.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.2 | GO:0035671 | enone reductase activity(GO:0035671) |
0.1 | 0.1 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.9 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.3 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.1 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.1 | 2.0 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.6 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.1 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.1 | 0.5 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.1 | GO:0016876 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 0.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 0.4 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 1.5 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.3 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 0.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.4 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 0.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.1 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 0.5 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.6 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 10.0 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 1.6 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.3 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.2 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.1 | 0.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 1.3 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.2 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.3 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.0 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.0 | 0.4 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.9 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 2.8 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.0 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 7.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.0 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.0 | 0.2 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.5 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.0 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 1.0 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.0 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.0 | 0.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.1 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.0 | 0.0 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 0.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.5 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 0.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.0 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.4 | GO:0005402 | cation:sugar symporter activity(GO:0005402) |
0.0 | 1.9 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.4 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.7 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.4 | GO:0017069 | snRNA binding(GO:0017069) |
0.0 | 0.1 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.0 | 0.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.5 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 1.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.8 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 3.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 1.2 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 0.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.6 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 2.1 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 0.2 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.0 | 0.1 | GO:0016208 | AMP binding(GO:0016208) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 2.1 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.3 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.0 | 0.2 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 2.4 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.0 | 0.0 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.0 | 0.1 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.0 | 0.0 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.3 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.2 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.0 | 0.2 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.0 | 0.1 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.1 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.2 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.5 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.0 | GO:0051425 | PTB domain binding(GO:0051425) |
0.0 | 0.3 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.7 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.0 | 0.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 0.8 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.2 | GO:0051861 | glycolipid binding(GO:0051861) |
0.0 | 0.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.1 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.0 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.0 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.0 | GO:0060090 | binding, bridging(GO:0060090) |
0.0 | 0.6 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 0.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.3 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
0.0 | 0.0 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.0 | 0.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.1 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.0 | 0.2 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 0.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.2 | GO:0034869 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.0 | 1.1 | GO:0015405 | primary active transmembrane transporter activity(GO:0015399) P-P-bond-hydrolysis-driven transmembrane transporter activity(GO:0015405) |
0.0 | 0.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.1 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.0 | 0.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.0 | 0.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.0 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.0 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.0 | 0.6 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.0 | 0.0 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.1 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 1.7 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.0 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.0 | 0.0 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 0.7 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 2.5 | GO:0061134 | peptidase regulator activity(GO:0061134) |
0.0 | 0.0 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.5 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.0 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.0 | 0.0 | GO:0051379 | epinephrine binding(GO:0051379) |
0.0 | 0.1 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.5 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.0 | 0.0 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.0 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.0 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.2 | GO:0051287 | NAD binding(GO:0051287) |
0.0 | 0.0 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.0 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.0 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.2 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.2 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.1 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
0.0 | 0.0 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.0 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.0 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.1 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.1 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.0 | 0.6 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.4 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 0.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.3 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.0 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.2 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.0 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 3.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.4 | 0.8 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.4 | 4.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 8.8 | ST GAQ PATHWAY | G alpha q Pathway |
0.3 | 9.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.3 | 0.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.3 | 6.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 7.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 2.9 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 2.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.3 | 2.0 | ST STAT3 PATHWAY | STAT3 Pathway |
0.3 | 0.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 7.9 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 4.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 9.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 4.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 13.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 3.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 3.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 8.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 3.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 4.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 2.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 5.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 3.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 5.6 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 3.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 1.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 1.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 4.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 4.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 0.6 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 5.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 1.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 6.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 0.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 2.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 3.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 4.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 3.3 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 0.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 0.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 2.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 1.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 0.7 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 5.7 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 0.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 1.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.2 | 1.1 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 1.9 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 0.9 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 5.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 0.8 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 3.3 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 2.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 1.7 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 1.9 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 5.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 0.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 2.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 2.0 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.5 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 0.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 4.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.5 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 1.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 1.7 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 8.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.7 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 1.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 1.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 3.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 1.2 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 0.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.8 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 2.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 1.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 2.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.4 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 1.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 1.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 1.7 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 1.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.6 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 2.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 0.7 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 0.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 1.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.5 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.0 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 0.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 4.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 2.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.1 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.1 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.0 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.4 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 1.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.5 | 7.1 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.5 | 8.2 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.4 | 4.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.4 | 3.6 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.4 | 0.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 6.0 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.3 | 3.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 5.2 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.3 | 8.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.3 | 3.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.3 | 2.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 2.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 3.1 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.3 | 2.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.3 | 3.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.3 | 2.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.3 | 7.3 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 2.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 2.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.3 | 1.3 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.3 | 2.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 2.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 4.9 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 1.0 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.2 | 1.9 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 18.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 3.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 0.9 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.2 | 7.7 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 1.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 2.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 2.0 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 1.4 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.2 | 1.6 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.2 | 20.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 2.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 1.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 2.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 0.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 3.9 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.2 | 3.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 2.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 4.7 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.2 | 1.4 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.2 | 2.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 2.8 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 4.9 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.2 | 0.7 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.2 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 1.1 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.2 | 4.4 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.2 | 0.4 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.2 | 2.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 0.5 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.2 | 1.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 4.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 0.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.2 | 0.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.2 | 2.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 15.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 3.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 3.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 0.6 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.2 | 1.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 0.5 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.2 | 3.1 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 1.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 4.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 0.1 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 3.7 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.1 | 1.0 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 6.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 2.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 3.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 2.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 1.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 2.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 1.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 1.3 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 1.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 1.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 1.6 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 1.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 1.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 0.1 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
0.1 | 1.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.9 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 4.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.6 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 1.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 2.5 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 1.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 1.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 1.9 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 0.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 1.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 1.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 1.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.1 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.1 | 1.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.6 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 1.5 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 1.9 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 0.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.3 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.1 | 3.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 0.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 2.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 0.9 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 2.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 1.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 0.1 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 0.9 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 0.4 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 0.9 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 0.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 3.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.1 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.1 | 1.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 8.8 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.1 | 1.3 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.1 | 0.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 2.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 2.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.7 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 1.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 4.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 1.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.6 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 1.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 0.6 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 1.5 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 1.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 9.2 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.1 | 0.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.7 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 1.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.4 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 1.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 1.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.8 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 1.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.9 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 2.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 0.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 13.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.8 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 0.1 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.1 | 1.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 0.4 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 1.2 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.1 | 0.5 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 0.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.6 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.1 | 4.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 1.0 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 0.3 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 5.3 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 1.0 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 2.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 2.6 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 0.7 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.1 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 0.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 0.6 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.6 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 0.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 2.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 2.1 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 0.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 0.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 0.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.7 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 0.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.1 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.1 | 0.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.4 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 1.8 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 0.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 1.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.6 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 1.1 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.5 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.0 | 1.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 1.6 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 3.7 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.5 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 0.0 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.2 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.7 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.6 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.0 | 0.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.4 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 1.0 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.1 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.0 | 0.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.4 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.3 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.1 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.0 | 0.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.2 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.0 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.0 | 0.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.1 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.6 | REACTOME INNATE IMMUNE SYSTEM | Genes involved in Innate Immune System |
0.0 | 0.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 0.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.2 | REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION | Genes involved in Post-translational protein modification |